2016
DOI: 10.1038/srep30111
|View full text |Cite
|
Sign up to set email alerts
|

Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism

Abstract: Non-alcoholic fatty liver disease (NAFLD) is one of the most frequent causes of liver disease and its prevalence is a serious and growing clinical problem. Caloric restriction (CR) is commonly recommended for improvement of obesity-related diseases such as NAFLD. However, the effects of CR on hepatic metabolism remain unknown. We investigated the effects of CR on metabolic dysfunction in the liver of obese diabetic db/db mice. We found that CR of db/db mice reverted insulin resistance, hepatic steatosis, body … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
61
1
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 78 publications
(72 citation statements)
references
References 53 publications
9
61
1
1
Order By: Relevance
“…Levels of LCN2 in serum, liver, brain, and adipose tissue are elevated in several murine models of obesity 9,48-50 . In previous studies, we demonstrated that CR attenuates serum, liver, and hippocampus LCN2 levels in db/db and ob/ob mice 48,49 . As circulating LCN2 increases in patients with heart failure, the production of LCN2 in the heart increases 51 , and in vitro treatment of cardiomyocytes with LCN2 causes iron accumulation and oxidative stress through increased 24p3R expression 52,53 .…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…Levels of LCN2 in serum, liver, brain, and adipose tissue are elevated in several murine models of obesity 9,48-50 . In previous studies, we demonstrated that CR attenuates serum, liver, and hippocampus LCN2 levels in db/db and ob/ob mice 48,49 . As circulating LCN2 increases in patients with heart failure, the production of LCN2 in the heart increases 51 , and in vitro treatment of cardiomyocytes with LCN2 causes iron accumulation and oxidative stress through increased 24p3R expression 52,53 .…”
Section: Discussionmentioning
confidence: 84%
“…This feeding restricted amounts in ob/ob mice maintained the body weight of ob/ob mice and further extended almost 50% of longevity comparable to that of mice fed ad libitum 57 . In Experiment 3, db/m and db/db mice were also randomly divided into four groups at 10 weeks of age; db/m and db/db mice were given free access to food and db/db+CR and db/m+CR mice were transferred to individual cages with restricted food (2 g/day) for 12 weeks, as previously described 49 .…”
Section: Methodsmentioning
confidence: 99%
“…Thus, acutely activating autophagy with caloric restriction, physical exercise, rapamycin, CRMs (that is, <m>metformin</m> or resveratrol), AMPK-targeting agents or hydrogen sulfide limits non-alcoholic steatohepatitis (NASH) and/or improves various metabolic parameters (including body weight, circulating glucose or triglyceride levels, and insulin sensitivity) in 24-month-old rats 128 , rodents that had been fed a HFD 129133 , mice acutely or chronically exposed to ethanol 134 as well as in <m> db / db mice</m> or <m> ob / ob mice</m> (which are two genetic models of hyperphagia and thus metabolic syndrome) 130,135,136 . Moreover, activation of autophagy with carbamazepine considerably reduced hepatic fibrosis in a model of α1<m>-antitrypsin deficiency</m>-associated liver disease 137 .…”
Section: Autophagy As a Therapeutic Targetmentioning
confidence: 99%
“…Moderate CR decreases visceral fat and blood pressure and improves the lipid profile, glucose uptake, and insulin sensitivity, and hearts from CR rodents show an improved ischemic tolerance 1316. Furthermore, CR preserves pancreatic mass and function by suppressing apoptosis in the db/db mouse,17 attenuates the development of hepatic steatosis in the db/db mice,18 and decreases adiposity in the genetically hyperphagic OLEFT model of type 2 diabetes 19. Taken together, it is clear that the benefits of ET and CR share a common favorable outcome on cardiovascular and metabolic health 20…”
Section: Introductionmentioning
confidence: 99%